• CHROMID range for SMART resistance management

CHROMID® range for SMART resistance management

Culture media range to fight Antimicrobial Resistance and HAI

Help fight Antimicrobial Resistance and Healthcare Associated Infections (HAI) with a range of chromogenic media designed specifically to provide reliable screening for relevant pathogens

  • Range designed specifically for today’s microbiology challenges
  • Sensitivity & specificity for reliable results
  • Easy to read thanks to color intensity & specificity
Add to my selection

Do you need more information

The fight against drug resistance and Healthcare Associated Infections

Growing resistance of organisms to antimicrobial therapies is causing major patient-care and economic challenges for healthcare systems. Some organisms – referred to as multi-drug resistant organisms (MDRO) – are becoming resistant to multiple types or classes of antimicrobials. Resistant organisms are also frequently involved in the spread of Healthcare Associated Infections (HAI). That’s why, for best patient care and to prevent the spread of disease, it is critical to implement appropriate antimicrobial therapy as soon as possible, based on rapid testing to identify the pathogens involved and test for their resistance. Not responding appropriately could be “potentially catastrophic,” as stated by the CDC in its recently released report on Antibiotic Resistance Threats1.

Leveraging our expertise in high-quality chromogenic culture media, bioMérieux brings you theCHROMID® chromogenic media range conveniently brought together for “SMARTsolutions to test for some of the “top-offenders” in drug resistance and HAI.

  • Standardized method: antibiotic concentration is controlled for each batch
  • Can be used on bioMérieux’s PREVI® Isola automated agar plate inoculation system for better colony isolation
  • Easy to read: many plates include chromogenic substrates and peptones to enable specific coloration for clear identification
  • Decrease the number of confirmation tests thanks to high performance
    • Time saving
    • Cost saving
    • Lower workload
  • A Certificate of Compatibility ensures compatibility with complementary products, including ID/AST

1. Antibiotic Resistance Threats in the United States, CDC 2013



  • Bi-plate offering smart association ofCHROMID® CARBA andCHROMID® OXA-48
  • Screening of all carbapenemase producer Enterobacteriaceae, including OXA-48, KPC and NDM-1 and more
  • Validated for both rectal swabs and stool specimens
  • Identification:18/24 hours


Show in media library: 


  • Direct identification of MRSA
  • Improved recovery of mecC MRSA
  • Less additional work thanks to 99.6% specificity
  • Identification: 18 hours


  • Patented mix of antibiotics for selective growth of extended-Spectrum ß-lactamase-producing Enterobacteriaceae (ESBL) offers high sensitivity
  • Patented mix of 3 substrates to enable direct identification of the most frequent ESBL
  • Isolation and identification of E. coli, KESC*, Proteus ESBL producers
  • Identification: 18 hours

    * Klebsiella, Enterobacter, Serratia and Citrobacter


  • Specific and selective isolation and detection of acquired Vancomycin-Resistant enterococci (VRE)
  • Differentiation of Vancomycin-Resistant E. faecium and E. faecalis
  • Detection of VanA and VanB genotypes
  • Selective mix inhibits enterococci with natural resistance (VanC), most Gram-negative and Gram-positive bacteria, and yeasts

CHROMID® C. difficile

  • Chromogenic medium for the detection and identification of Clostridium difficile in stools of symptomatic patients
  • Rich nutritive base and patented chromogenic substrates to detect specific metabolic enzymes for C. difficile
  • Antibiotic mixture inhibits most Gram-negative and Gram-positive bacteria, yeasts and molds
  • Identification of C. difficile in 24 hours


  • Detection of two MDROs
  • Screening of extended-Spectrum ß-lactamase-producing Enterobacteriaceae (ESBL)
  • Detection and differentiation of Enterococcus faecium and Enterococcus faecalis showing acquired Vancomycin resistance (VRE)

BLSE agar

  • Screening of extended-Spectrum ß-lactamase-producing Enterobacteriaceae (ESBL) and Gram-negative bacilli


CHROMID® range for SMART resistance management: technical specifications and reference numbers
CHROMID® CARBA SMART 414685 20 biplates x 90 mm
CHROMID® MRSA SMART 413050 413051 20 x 90 mm 100 x 90 mm
CHROMID ® ESBL 43481 20 x 90 mm
CHROMID® VRE 43004 20 x 90 mm
CHROMID® C.difficile 43871 20 x 90 mm
CHROMID® ESBL / CHROMID® VRE 43470 20 biplates x 90 mm
BLSE agar AEB 5225770 20 x 90 mm


  1. Practical Guide for the prevention of healthcare associated infections

  2. bioMérieux TV: Outsmarting antimicrobial resistance 2011 

Pioneering diagnostics